Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Radomysl

2 clinical trials in Radomysl, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Radomysl at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Radomysl

Open in trial search

COVID-19

Recruiting

Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

Investigational
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ibuzatrelvir
  • Sponsor:Pfizer Inc.

Erythema migrans+1

Not recruiting

Study on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Biocodex

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Radomysl

What the registry says about research in the country

01 Virus Diseases

Clinical research in Radomysl is focused on virus diseases, especially COVID-19 in people at risk of developing severe illness. The studies are designed to evaluate a new treatment approach and help identify better options for managing infection outside the hospital.

  • COVID-19 in nonhospitalized patients
  • High risk of progression to severe disease
  • Testing a potential antiviral therapy

These trials aim to improve treatment effectiveness and support earlier care for patients who may need closer monitoring.

02 Digestive System Diseases

Another active area is digestive system diseases, with research centered on the gut effects of treatment in patients receiving antibiotic therapy for erythema migrans, the early skin form of Lyme borreliosis. The work explores ways to protect intestinal balance during infection treatment.

  • Gut microbiota changes during antibiotic use
  • Erythema migrans in Lyme borreliosis
  • Supportive care for patients on antibiotics

The trials are evaluating whether a probiotic-based approach and related treatment strategies can help maintain digestive health while infection is being treated.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.